Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate

Phospho-sulindac (P-S), a promising anticancer agent, is efficacious in pre-clinical models of human cancer and is apparently safe. Here, we studied the effect of P-S on pancreatic cancer growth. We found that P-S strongly inhibits the growth of human pancreatic cancer cells in vitro, is efficacious...

Descripción completa

Detalles Bibliográficos
Autores principales: MURRAY, ONIKA T., WONG, CHI C., VRANKOVA, KVETOSLAVA, RIGAS, BASIL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898803/
https://www.ncbi.nlm.nih.gov/pubmed/24284479
http://dx.doi.org/10.3892/ijo.2013.2190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3898803/
https://www.ncbi.nlm.nih.gov/pubmed/24284479
http://dx.doi.org/10.3892/ijo.2013.2190

Ejemplares similares